25-hydroxyvitamin D Concentration (Vitamin D Status)
Conditions
Keywords
Vitamin D, Fortified milk, Supplementation, UV exposure, Winter, Healthy adults, Body Composition, Muscle function, Blood pressure
Brief summary
Vitamin D insufficiency has become a global concern, with low vitamin D status associated with bone disorders, cardiovascular disease and certain cancers. The United Kingdom (UK) and Ireland are at particular risk of vitamin D deficiency owing to the northerly latitude, increased use of sunscreen, decreased sun exposure and a high level of cloud cover. A recent survey in the UK showed that more than 50% of UK adults have insufficient vitamin D status, with lower levels noted in the winter months. Variations in vitamin D status have been known to vary between summer and winter, owing to our northern latitude (52-55°N) the Ultraviolet (UV)-B intensity in Northern Ireland is inadequate to promote the dermal synthesis of vitamin D during the winter months, causing us to rely on dietary sources. The aim of this intervention is to investigate the main effects of vitamin D3-fortified milk and supplemental vitamin D3 on vitamin D status and functional health outcomes during the winter, and how this intervention will affect subsequent dermal synthesis of vitamin D from UV exposure. Participants will be recruited from the local community. Blood samples will be collected from each participant at two timepoints (September/October and March/April). Pre- and post-intervention blood pressure, grip strength, height, weight, waist and hip circumferences will be measured, in addition participants will undergo a dual energy x-ray absorptiometry (DXA) scan to assess body composition and bone mineral density. Information on general health, lifestyle, physical activity, dietary intake and typical behaviours in the sun will be collected. Following the dietary intervention, a subset of participants will be invited to participate in a follow-up study, examining UV exposure during the summer months, when they will wear a personal wrist dosimeter for 1 month, complete a sun dairy and provide 2 additional blood samples.
Interventions
DIETARY_SUPPLEMENTFortified milk (10µg vitamin D3)
DIETARY_SUPPLEMENTUnfortified milk (placebo)
DIETARY_SUPPLEMENT10µg vitamin D3 supplement
DIETARY_SUPPLEMENTPlacebo supplement
Sponsors
Dairy Council for Northern Ireland
Agri-Food and Biosciences Institute
Center for Nutrition and Health, RIVM (The Netherlands)
University of Ulster
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* 20-40 years old * Apparently healthy * Living on the island of Ireland
Exclusion criteria
* Below 20 years and aged 40 years or above * Not living on the island of Ireland * Pregnant or lactating women and those planning to become pregnant * Individuals who have been taking a vitamin D or calcium containing supplement in the previous three months * Those with food intolerances or allergies that would affect their ability to consume study milk * Individuals following a diet which excludes milk (e.g. vegans) * Those with a diagnosed chronic medical condition or on prescribed medication known to effect vitamin D metabolism * Those who are planning a sun holiday during the winter months (Oct-Mar) * Adults with learning, or any other difficulties that would prevent them from completing the study protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in vitamin D status (25-hydroxyvitamin D serum concentration) | Baseline + post-intervention (24weeks) | Blood analysis |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in body composition | Baseline + post-intervention (24weeks) | Assessed by dual energy X-ray absorptiometry (DXA) |
| Change in muscle strength | Baseline + post-intervention (24weeks) | Assessed by grip strength |
| Change in inflammation status | Baseline + post-intervention (24weeks) | Blood analysis |
| Change in glucose levels | Baseline + post-intervention (24weeks) | Blood analysis |
| Change in insulin concentrations | Baseline + post-intervention (24weeks) | Blood analysis |
| Change in lipid profile | Baseline + post-intervention (24weeks) | Blood analysis |
Other
| Measure | Time frame | Description |
|---|---|---|
| UV exposure (follow-up) | 8 weeks post-intervention (32-40 weeks) | Assessed by UV wrist monitors |
Countries
United Kingdom
Outcome results
None listed